Diuretic-Resistant Ascites Following Laparoscopic Surgery in a Patient With Chronic Myeloid Leukemia on Imatinib Therapy

Imatinib mesylate is a tyrosine kinase inhibitor with high efficacy in the treatment of chronic myeloid leukemia (CML). Although fluid retention is a common adverse effect of imatinib, it rarely necessitates discontinuation of therapy. Isolated ascites has not been reported as a complication of imat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappa, Efthymia, Gkeka, Marina, Kiki, Ifigeneia, Gourna, Pagona, Christopoulos, Constantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935277/
https://www.ncbi.nlm.nih.gov/pubmed/33728144
http://dx.doi.org/10.7759/cureus.13127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935277/
https://www.ncbi.nlm.nih.gov/pubmed/33728144
http://dx.doi.org/10.7759/cureus.13127

Ejemplares similares